Vidaza
Vidaza Brand names, Vidaza Analogs
Vidaza Brand Names Mixture
- No information avaliable
Vidaza Chemical_Formula
C8H12N4O5
Vidaza RX_link
http://www.rxlist.com/cgi/generic3/vidaza.htm
Vidaza fda sheet
Vidaza msds (material safety sheet)
Vidaza Synthesis Reference
No information avaliable
Vidaza Molecular Weight
244.205 g/mol
Vidaza Melting Point
229 oC
Vidaza H2O Solubility
8.9E+004 mg/L
Vidaza State
Solid
Vidaza LogP
-3.017
Vidaza Dosage Forms
Azacitidine for injectable suspension is supplied as a lyophilized powder in 100 mg single-use vials packaged in cartons of 1 vial.
Vidaza Indication
For treatment of patients with the following myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia.
Vidaza Pharmacology
Azacitidine is believed to exert its antineoplastic effects by causing hypomethylation of DNA and direct cytotoxicity on abnormal hematopoietic cells in the bone marrow. The concentration of azacitidine required for maximum inhibition of DNA methylation in vitro does not cause major suppression of DNA synthesis. Hypomethylation may restore normal function to genes that are critical for differentiation and proliferation. The cytotoxic effects of azacitidine cause the death of rapidly dividing cells, including cancer cells that are no longer responsive to normal growth control mechanisms. Non-proliferating cells are relatively insensitive to azacitidine.
Vidaza Absorption
Azacitidine is rapidly absorbed after subcutaneous administration. The bioavailability of subcutaneous azacitidine relative to IV azacitidine is approximately 89%, based on area under the curve.
Vidaza side effects and Toxicity
One case of overdose with azacitidine was reported during clinical trials. A patient experienced diarrhea, nausea, and vomiting after receiving a single IV dose of approximately 290 mg/m2, almost 4 times the recommended starting dose.
Vidaza Patient Information
Vidaza Organisms Affected
Humans and other mammals
